Used as a chiral intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders and antidepressants. Its structure supports the development of selective serotonin reuptake inhibitors (SSRIs) due to the presence of the trifluoromethylphenyl group, which enhances metabolic stability and binding affinity. The Boc-protected amine allows for controlled deprotection and coupling in peptide-like synthesis, making it valuable in medicinal chemistry for building complex molecules with high enantiomeric purity.